Clinical Trial Update: Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing AC (doxorubicin/cyclophosphamide) versus Taxotere/Xeloda (docetaxel/capecitabine) as primary chemotherapy for Stage II–III breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED